Surgical or early menopause: why the timeline is different

Menopause is not one clock. If both ovaries were removed, or if periods stopped before 45, the calendar and the questions are not the same as a typical mid-50s transition. Surgical menopause is the sudden loss of ovarian hormones after both ovaries come out—not the same thing as a hysterectomy that leaves ovaries in place. Premature ovarian insufficiency (POI) is loss of ovarian activity before 40; early menopause is usually used for ages 40–44.

This page cannot diagnose you, and it cannot tell you to start hormone therapy. What it can do is name the difference so you can ask time-sensitive questions, and so a tracker can flag the right stage instead of treating you like a standard perimenopause.

If I had a hysterectomy, am I in menopause?

Not automatically. A hysterectomy removes the uterus. Periods stop, so the usual “12 months without a period” definition is hard to use. If one or both ovaries remain, they can still make hormones. That is not surgical menopause.

Surgical menopause means both ovaries were removed (bilateral oophorectomy) before a natural menopause. Hormone levels drop abruptly, often while you are recovering from an operation. A 2025 Women’s Health Concern factsheet, developed with the British Menopause Society, describes that sudden drop—especially estrogen—rather than the slower fade of a typical transition.

If you kept your ovaries, you may still move through perimenopause later. A 2023 Study of Women’s Health Across the Nation analysis found that hysterectomy with ovaries conserved did not show a faster drop in anti-Müllerian hormone than natural menopause. Without periods as a marker, you and your clinician watch symptoms, sleep, mood, and sexual changes.

If both ovaries are already gone, extra labs are not what confirms “menopause.” The 2024–2025 international POI guideline from ESHRE, ASRM, CRE-WHiRL, and the International Menopause Society says women who had both ovaries removed before 40 have a diagnosis of POI and do not need additional testing for that fact.

What do “premature” and “early” actually mean?

That guideline defines POI as loss of ovarian activity before age 40, with irregular cycles or no cycles plus biochemical confirmation (disordered cycles for at least four months and an FSH over 25 IU/L, repeated if the picture is unclear). “Early menopause” is cessation of ovarian function at ages 40–44. Recent publications cited there put the prevalence of non-iatrogenic POI around 3.5%, higher than the older “about 1%” figure.

MedlinePlus, from the National Library of Medicine, notes that POI is not always the same as “premature menopause”: some ovarian activity can continue, so contraception can still be a question if ovaries are intact. Causes include surgery, chemotherapy or radiation, genetic or autoimmune conditions, and, often, no clear cause.

Why does the stage flag on a tracker matter?

A typical perimenopause log assumes fluctuating hormones and a final period in the early 50s. If your last period was at 38, or ovaries were removed at 44, the same symptom list sits on a different timeline.

Bone, heart, mood, cognition, sexual health, and work are the domains societies keep naming for earlier estrogen loss. The Menopause Society, reporting a 2025 study in Menopause, notes that menopause before 45 is associated with higher risk of cardiovascular disease and osteoporosis, and that surgical menopause can mean a sudden stop of ovarian function. That study also linked surgical menopause with a higher chance of leaving the labor market, especially when surgery happened at 45 or older.

Stage flags are not labels to fear. They keep a tool—and a visit—from treating you as “average age, average pace.” If a chart cannot record “both ovaries removed” or “final period before 45,” the advice stays generic.

What is time-sensitive to ask—without asking for a dose?

The 2022 hormone therapy position statement of The North American Menopause Society (now The Menopause Society) states that women with POI and premature or early menopause have higher risks of bone loss, heart disease, and cognitive or affective disorders associated with estrogen deficiency. It says hormone therapy can be used until at least the mean age of menopause unless there is a contraindication. The 2024–2025 POI guideline likewise discusses hormone therapy until the usual age of menopause as a long-term health question, not only hot flashes.

Those are society statements to talk through with a clinician. They are not a green light from this article, and they are not a dose. Some women cannot use hormones. Cancer history, clot risk, migraine, and preference all change the conversation. If surgery is still ahead, asking before the operation is often more useful than asking six months later.

No one here will tell you to start HRT, a supplement, or any other treatment.

Questions to take to your clinician

• Were both ovaries removed, one, or neither—and how should that change what we watch?
• Do I meet criteria for POI or early menopause, and what records or labs (if any) do you still need?
• Given my age at surgery or last period, what should we discuss about bone, heart, mood, and sexual health now?
• Societies mention hormone therapy until the typical age of menopause for some women in this situation. Is that relevant for me—or not, and why?
• If hormones are not an option, what else do you monitor, and how often?
• Who else should be on this team (gynecology, endocrinology, primary care, mental health)?

This is not a diagnosis. Talk with your doctor about your operation, your age at last period, and what follow-up you need. A tracker that can flag surgical or early menopause, plus a sample doctor report with dates and symptoms, can make that visit shorter and clearer. Decisions about treatment stay in the exam room.

Sources

1. Panay N, Vincent AJ, et al. “Evidence-based guideline: Premature Ovarian Insufficiency.” ESHRE / ASRM / CRE-WHiRL / IMS. Fertility and Sterility. 2024–2025. https://www.asrm.org/practice-guidance/practice-committee-documents/evidence-based-guideline-premature-ovarian-insufficiency--2024/
2. The Menopause Society. “Women With Surgical Menopause May Exit Workforce Earlier, but Hormone Therapy Could Help.” October 8, 2025. https://menopause.org/press-releases/women-with-surgical-menopause-may-exit-workforce-earlier-but-hormone-therapy-could-help
3. The North American Menopause Society. “The 2022 hormone therapy position statement of The North American Menopause Society.” Menopause. 2022. https://menopause.org/docs/default-source/professional/nams-2022-hormone-therapy-position-statement.pdf
4. Women’s Health Concern / British Menopause Society. “Surgical menopause” factsheet. September 2025. https://www.womens-health-concern.org/wp-content/uploads/2025/09/37-NEW-WHC-FACTSHEET-Surgical-menopause-SEPT2025-B.pdf
5. MedlinePlus, National Library of Medicine. “Primary Ovarian Insufficiency.” https://medlineplus.gov/primaryovarianinsufficiency.html
6. Santoro N, et al. “Anti-Müllerian Hormone Level Decline in Patients Undergoing Hysterectomy With and Without Oophorectomy Compared With Natural Menopause.” Obstetrics & Gynecology. 2023. https://doi.org/10.1097/AOG.0000000000005049

Educational only. Not medical advice. No dosing. Last reviewed August 2026.

Not medical advice. Always talk to your doctor.